OneProjects Design & Innovation Ltd was established in 2017 as a joint spin-out company from NUIG and TCD. The company, with its HQ in Dublin and a second office in Munich, has developed a connected platform technology called Verafeye that is set to revolutionise the treatment of AFib and cardiac arrhythmias. Verafeye is a sensor-based technology that gathers unprecedented data from the heart in real-time. In June 2020, OneProjects closed a Series A funding round of €11 million co-led by Life Sciences Partners and the Atlantic Bridge University Fund with additional participation from Enterprise Ireland and several medtech entrepreneurs and investors.
“Trinity and NUIG provided access to excellent technical infrastructure, expertise and IP management. Start-up Development Manager, Licensing Manager and TTO Case Manager supported the campus company formation process and in particular were very involved in negotiating complex IP licensing arrangements.” CEO & Co-Founder, OneProjects – Fionn Lahart
Find out more about working with third-level research